ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Maria-Benedicta Edwards
Kenneth M. Taylor
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edwards, M.-B.
Right arrow Articles by Taylor, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edwards, M.-B.
Right arrow Articles by Taylor, K. M.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2003;76:482-485
© 2003 The Society of Thoracic Surgeons


Original article: cardiovascular

Is 30-day mortality an adequate outcome statistic for patients considering heart valve replacement?

Maria-Benedicta Edwards, MPhila*, Kenneth M. Taylor, FRCSa

a United Kingdom Heart Valve Registry, Department of Cardiothoracic Surgery, Hammersmith Hospital, London, United Kingdom

Accepted for publication February 15, 2003.

* Address reprint requests to Dr Edwards, UK Heart Valve Registry, Department of Cardiothoracic Surgery, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
e-mail: m.b.edwards{at}ic.ac.uk

BACKGROUND: In-hospital mortality is widely used by clinicians as a benchmark measure of outcome for determining risks/benefits of cardiac surgery. Patients, however, may wish to have information on estimated longer-term outcomes. Mortality risk by 1 year after the operation may be a more meaningful outcome statistic. We therefore undertook to determine 30-day and 365-day postoperative mortality rates in a large series of consecutive patients who have undergone heart valve replacement (HVR) surgery in the United Kingdom since 1986.

METHODS: Data on 80,757 patients registered on the UK Heart Valve Registry were analyzed. Kaplan–Meier actuarial survival analysis was calculated to determine 30-day (group 1) and 365-day (group 2) mortality. Cox proportional hazards were calculated for each group to identify significant risk factors for mortality less than 1 year.

RESULTS: Thirty-day mortality represents around half (56%) of the 365-day mortality. This ratio was robust for most subdivisions of the total population. Cox proportional hazards demonstrated female sex, age older than 70 years, single tricuspid valve replacement, multiple valve replacement regardless of type of valve, and subsequent valve operation as significant risk factors of early mortality (group 1). However, men were at significantly greater risk of late mortality (group 2). All other factors remained significant with the exception of subsequent valve operation, which was dropped from the model (group 2).

CONCLUSIONS: The robustness of these data would allow cardiologists and cardiac surgeons to provide preoperative patients with a reasonably accurate estimate of survival rates at 1 year after valve replacement surgery in addition to the customary short-term 30-day outcome.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
J. S. Gammie, J. W. Brown, J. M. Brown, R. S. Poston, R. N. Pierson III, P. N. Odonkor, C. S. White, J. S. Gottdiener, and B. P. Griffith
Aortic valve bypass for the high-risk patient with aortic stenosis.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1605 - 1610.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.